Baroudjian B - Search Results

1

Gauci ML, Baroudjian B, Herms F, Tetu P, Jebali M, Nicole N, Lebbé C. Gauci ML, et al. Among authors: baroudjian b. Rev Prat. 2021 Feb;71(2):123-132. Rev Prat. 2021. PMID: 34160967 French. No abstract available.

2

Arterial aneurysm with distal ischemia in a renal allografted patient: beware of angiosarcoma.

Baroudjian B, Battistella M, Mourah S, Hickman G, Pages C, Moulonguet I, Koskas F, Gaudric J, Le Maignan C, Dantal J, Bagot M, Petit A, Lebbe C. Baroudjian B, et al. Eur J Dermatol. 2013 May-Jun;23(3):410-1. doi: 10.1684/ejd.2013.2020. Eur J Dermatol. 2013. PMID: 23783091 No abstract available.

3

Reply to 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance' by Funck-Brentano et al.

Goldwirt L, Chami I, Feugeas JP, Pages C, Brunet-Possenti F, Allayous C, Baroudjian B, Madelaine I, Sauvageon H, Mourah S, Lebbé C. Goldwirt L, et al. Among authors: baroudjian b. Ann Oncol. 2016 Feb;27(2):363-4. doi: 10.1093/annonc/mdv538. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578723 Free article. No abstract available.

4

[Melanoma, from diagnosis to treatment].

Baroudjian B, Pagès C, Lebbé C. Baroudjian B, et al. Rev Infirm. 2016 Mar;(219):16-8. doi: 10.1016/j.revinf.2015.12.022. Rev Infirm. 2016. PMID: 26944639 Review. French.

5

Anti-PD1-induced collagenous colitis in a melanoma patient.

Baroudjian B, Lourenco N, Pagès C, Chami I, Maillet M, Bertheau P, Bagot M, Gornet JM, Lebbé C, Allez M. Baroudjian B, et al. Melanoma Res. 2016 Jun;26(3):308-11. doi: 10.1097/CMR.0000000000000252. Melanoma Res. 2016. PMID: 26990271

6

Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.

Danlos FX, Pagès C, Baroudjian B, Vercellino L, Battistella M, Mimoun M, Jebali M, Bagot M, Tazi A, Lebbé C. Danlos FX, et al. Among authors: baroudjian b. Chest. 2016 May;149(5):e133-6. doi: 10.1016/j.chest.2015.10.082. Chest. 2016. PMID: 27157227

7

Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.

Felix J, Cassinat B, Porcher R, Schlageter MH, Maubec E, Pages C, Baroudjian B, Homyrda L, Boukouaci W, Tamouza R, Bagot M, Caignard A, Toubert A, Lebbé C, Moins-Teisserenc H. Felix J, et al. Among authors: baroudjian b. Int Immunopharmacol. 2016 Nov;40:466-473. doi: 10.1016/j.intimp.2016.09.030. Epub 2016 Oct 8. Int Immunopharmacol. 2016. PMID: 27728898

8

Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients.

Amode R, Baroudjian B, Kowal A, Jebali M, Allayous C, Bagot M, Madjlessi N, Roux J, Viguier M, Basset Seguin N, Porcher R, Pagès C, Lebbé C. Amode R, et al. Among authors: baroudjian b. Melanoma Res. 2017 Apr;27(2):110-115. doi: 10.1097/CMR.0000000000000313. Melanoma Res. 2017. PMID: 27926587

9

Immunothérapie et mélanome : l’exemple des anticorps immunomodulateurs.

Pagès C, Baroudjian B, Lebbé C. Pagès C, et al. Among authors: baroudjian b. Bull Cancer. 2016 Nov;103 Suppl 1:S132-S137. doi: 10.1016/S0007-4551(16)30370-8. Bull Cancer. 2016. PMID: 28057176 French.

10

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.

Gauci ML, Baroudjian B, Laly P, Madelaine I, Da Meda L, Vercellino L, Bagot M, Lioté F, Pages C, Lebbé C. Gauci ML, et al. Among authors: baroudjian b. Semin Arthritis Rheum. 2017 Oct;47(2):281-287. doi: 10.1016/j.semarthrit.2017.03.003. Epub 2017 Mar 8. Semin Arthritis Rheum. 2017. PMID: 28438383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page